Oleksandr N Kryvenko Selected Research

Oleksandr N Kryvenko Research Topics

Disease

44	Neoplasms (Cancer) 04/2024 - 05/2012
31	Prostatic Neoplasms (Prostate Cancer) 11/2023 - 07/2012
6	Renal Cell Carcinoma (Grawitz Tumor) 12/2022 - 11/2014
6	Adenocarcinoma 01/2022 - 10/2012
4	Carcinoma (Carcinomatosis) 12/2022 - 05/2013
4	Neoplasm Metastasis (Metastasis) 10/2022 - 09/2012
4	Margins of Excision 01/2022 - 05/2012
3	Necrosis 11/2023 - 12/2016
3	Thrombosis (Thrombus) 01/2019 - 09/2011
2	Oxyphilic Adenoma (Oncocytoma) 09/2021 - 11/2014
2	Kidney Neoplasms (Kidney Cancer) 09/2021 - 01/2017
2	COVID-19 07/2021 - 01/2021
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2021 - 07/2013
2	Prostatic Intraepithelial Neoplasia 01/2021 - 08/2013
2	Inflammation (Inflammations) 01/2019 - 07/2012
2	Carcinogenesis 07/2018 - 01/2013
2	Disease Progression 06/2016 - 02/2014
2	Obesity 04/2016 - 05/2013
2	Lymphatic Metastasis 05/2013 - 10/2012
1	Malignant Mesothelioma 01/2024
1	Small Cell Carcinoma 05/2023
1	Adenoma (Adenomas) 01/2023
1	Diverticulum 01/2023
1	Urinary Calculi (Urinary Calculus) 01/2023
1	Medullary Carcinoma 12/2022
1	Non-Muscle Invasive Bladder Neoplasms 01/2022
1	Lower Urinary Tract Symptoms 11/2021
1	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 11/2021
1	Perivascular Epithelioid Cell Neoplasms 09/2021
1	renal Oncocytoma 09/2021
1	Osteomyelitis 01/2021
1	Urinary Retention 01/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2017
1	Cysts 01/2017
1	Metaplasia 12/2016
1	Granuloma 12/2016
1	Fibrosis (Cirrhosis) 12/2016
1	Alzheimer Disease (Alzheimer's Disease) 10/2016

Drug/Important Bio-Agent (IBA)

11	Prostate-Specific Antigen (Semenogelase)IBA 02/2024 - 05/2012
4	Keratin-7 (Cytokeratin 7)IBA 11/2023 - 11/2014
4	Cisplatin (Platino)FDA LinkGeneric 08/2023 - 01/2017
4	Proteins (Proteins, Gene)FDA Link 07/2021 - 06/2013
3	GP 4 (GP4)IBA 02/2024 - 01/2021
3	Phenobarbital (Luminal)FDA Link 01/2022 - 07/2013
2	N-acetyltalosaminuronic acid (NAT)IBA 11/2023 - 09/2022
2	ProdrugsIBA 08/2023 - 07/2023
2	AndrogensIBA 05/2023 - 04/2014
2	Keratin-5 (Keratin 5)IBA 05/2022 - 01/2022
2	2-(4-toluidino)-6-naphthalenesulfonic acid (TNS)IBA 01/2022 - 01/2021
2	Microphthalmia-Associated Transcription FactorIBA 09/2021 - 11/2014
2	CarcinogensIBA 07/2018 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 06/2016 - 07/2013
2	DNA AdductsIBA 08/2013 - 01/2013
1	LipidsIBA 04/2024
1	Keratin-20 (Cytokeratin 20)IBA 11/2023
1	Estrogen ReceptorsIBA 11/2023
1	Progesterone Receptors (Progesterone Receptor)IBA 11/2023
1	ThuliumIBA 11/2023
1	HolmiumIBA 11/2023
1	AntibodiesIBA 05/2023
1	N 30IBA 01/2023
1	Fumarate Hydratase (Fumarase)IBA 12/2022
1	Thyroglobulin FDA Link 10/2022
1	Keratins (Keratin)IBA 01/2022
1	Sirolimus (Rapamycin)FDA Link 09/2021
1	Cathepsin KIBA 09/2021
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 07/2021
1	erucylphosphocholineIBA 07/2021
1	Viral RNAIBA 07/2021
1	Coloring Agents (Dyes)IBA 01/2021
1	Adalimumab (Humira)FDA Link 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	pazopanib FDA Link 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	arginyltransferaseIBA 01/2019
1	NivolumabIBA 01/2019
1	EnzymesIBA 01/2019
1	CadmiumIBA 07/2018
1	Androgen Receptors (Androgen Receptor)IBA 07/2018
1	Capsules (Microcapsules)IBA 01/2017
1	CholesterolIBA 12/2016
1	Amyloid (Amyloid Fibrils)IBA 10/2016
1	Peptides (Polypeptides)IBA 10/2016
1	Hormones (Hormone)IBA 10/2016

Therapy/Procedure

28	Prostatectomy (Retropubic Prostatectomy) 02/2024 - 05/2012
9	Therapeutics 01/2024 - 03/2015
5	Nephrectomy 01/2019 - 09/2014
4	Radiotherapy 01/2023 - 06/2016
3	Drug Therapy (Chemotherapy) 02/2019 - 06/2013
2	Catheters 01/2023 - 06/2013
2	Neoadjuvant Therapy 01/2022 - 01/2017
2	Solid-State Lasers 11/2021 - 01/2020
2	Transurethral Resection of Prostate (TURP) 01/2020 - 05/2013
2	Cystectomy 02/2019 - 01/2017
1	Lasers (Laser) 11/2023
1	Replantation 01/2023
1	Transurethral Resection of Bladder 01/2023
1	Contraindications 01/2020
1	Thrombectomy 01/2019
1	Cryosurgery 01/2017